PANK1 and cancer: However, the consistent and reliable results that we obtained with MDA-299-62A from well-controlled experiments show that the antibody is robust enough to study the genetic interactions of PANK isoform knockout for the purposes of validating PANK proteins as collateral lethality targets in cancer.